Study shows that a 5:2 intermittent fasting meal replacement diet effectively controls blood glucose levels and reduces body weight in Chinese adults with early type 2 diabetes. This dietary intervention outperforms metformin and empagliflozin in managing diabetes and obesity.
HGP Releases Health IT Private Equity Investment Trends for 2024
privat What You Should Know: – Healthcare Growth Partners (HGP) and Eliciting Insights surveyed private equity investment professionals focused on the Healthcare and Health IT
November 6, 2024